MedTrace Logo

Ultrasound Applicability in the Assessment of Patients With Fibrosing Interstitial Lung Disease

NCT06844331 · Status: ENROLLING_BY_INVITATION · Type: OBSERVATIONAL · Enrollment: 117

Last updated 2025-08-07

No results posted yet for this study

Summary

In this study the investigators want to examine the different ultrasound techniques to assess the patients with lung fibrosis.

The investigators want to followup these patients in 1 year to see the changes in lungs, pleura, diaphragm and measurments of overarm and thigh muscles to see that the investigators can identify the patients with lung fibrosis with this methods and monitor the progression.

Now a days the CT scan in the lungs needs to monitor these participants, but the investigators want to see the ultrasound can use insted for CT scanning to minitor these pateints.

These patient group has very bad prognosis, so it is necessary to identify these patients as early as possible to treatments.

Conditions

  • Fibrosing Interstitial Lung Diseases
  • Thoracic Ultrasound

Interventions

DEVICE

Thoracic ultrasound

The investigators want to investigate that TUS/US can use to identify and to monitir the disease progression in the patients with F-ILD

Sponsors & Collaborators

  • Odense University Hospital

    lead OTHER

Principal Investigators

  • Jesper R Davidsen, MD,PhD · Department of Respiratory Medicine, Odense University Hospital

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-10-21
Primary Completion
2026-05-31
Completion
2026-05-31

Countries

  • Denmark

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06844331 on ClinicalTrials.gov